EGeen

Executive Summary

EGeen International, Inc. is a specialized Contract Research Organization (CRO) headquartered in Cambridge, US, founded in 2019. The company focuses on providing full-service clinical trial management with an emphasis on rapid patient recruitment, trial design, monitoring, and regulatory affairs across multiple therapeutic areas, notably gene therapy and ophthalmology. By leveraging a global network, EGeen aims to deliver cost-effective and timely results for biotech and pharmaceutical clients. As a service-based company, its business model offers recurring revenue streams and scalability, though it operates in a competitive CRO market. The company's growth prospects hinge on expanding its client base, entering new geographies, and developing strategic partnerships to enhance its service offerings.

Upcoming Catalysts (preview)

• Q3 2026Announcement of a major contract with a top-tier pharmaceutical company40% success
• Q4 2026Expansion of clinical trial services into a new therapeutic area or geographic region50% success
• Q2 2026Launch of a proprietary technology platform to accelerate patient recruitment30% success